Show simple item record

dc.contributor.advisor© 2016 The Author(s)
dc.contributor.authorMcArthur, Sen_US
dc.contributor.authorLoiola, RAen_US
dc.contributor.authorMaggioli, Een_US
dc.contributor.authorErrede, Men_US
dc.contributor.authorVirgintino, Den_US
dc.contributor.authorSolito, Een_US
dc.date.accessioned2016-11-02T11:40:26Z
dc.date.available2016-09-03en_US
dc.date.issued2016-09-21en_US
dc.date.submitted2016-09-22T14:21:15.391Z
dc.identifier.other10.1186/s12987-016-0043-0
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/16229
dc.descriptionThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/ publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en_US
dc.description.abstractAnnexin A1 is a potent anti-inflammatory molecule that has been extensively studied in the peripheral immune system, but has not as yet been exploited as a therapeutic target/agent. In the last decade, we have undertaken the study of this molecule in the central nervous system (CNS), focusing particularly on the primary interface between the peripheral body and CNS: the blood-brain barrier. In this review, we provide an overview of the role of this molecule in the brain, with a particular emphasis on its functions in the endothelium of the blood-brain barrier, and the protective actions the molecule may exert in neuroinflammatory, neurovascular and metabolic disease. We focus on the possible new therapeutic avenues opened up by an increased understanding of the role of annexin A1 in the CNS vasculature, and its potential for repairing blood-brain barrier damage in disease and aging.en_US
dc.description.sponsorshipSM is supported by Alzheimer’s Research UK (Grant# ARUK-PPG2016B-6) and the Society for Endocrinology (Early Career Grant); RAL is funded by the CAPES Foundation, Ministry of Education, Brazil (Grant#7326/2014-09). DV is supported by Regional Technology Clusters, Regione Puglia, 2015 (cod. MTJU9H8) and by FCRP-Fondazione Cassa di Risparmio di Puglia, 2015. ES is supported by Alzheimer’s Research UK (Grant# ARUK-PPG2013B-2) and FISM-Fondazione Italiana Sclerosi Multipla-cod.2014/R/21.en_US
dc.format.extent17 - ?en_US
dc.languageengen_US
dc.language.isoenen_US
dc.relation.ispartofFluids Barriers CNSen_US
dc.rightsThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
dc.rightsCreative Commons Attribution 4.0 International License
dc.subjectAnnexin A1en_US
dc.subjectBlood–brain barrieren_US
dc.subjectInflammationen_US
dc.subjectMetabolismen_US
dc.subjectMultiple sclerosisen_US
dc.subjectStrokeen_US
dc.titleThe restorative role of annexin A1 at the blood-brain barrier.en_US
dc.typeArticle
dc.rights.holder© 2016 The Author(s)
dc.identifier.doi10.1186/s12987-016-0043-0en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/27655189en_US
pubs.issue1en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
pubs.volume13en_US
dcterms.dateAccepted2016-09-12en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record